Hyun Joseph Kim

6768014, Jul 27, 2004

Jun 27, 2002

10/169139

Hyun Koo Kim - Bethesda MD
Pemmaraju N. Rao - San Antonio TX
James W. Cessac - San Antonio TX
Anne Marie Simmons - San Antonio TX

The United States of America as represented by the Department of Health and Human Services - Washington DC

C07J 500

552595

A compound having general formula (I) in which R is a member selected from the group consisting of âOCH , âSCH , âN(CH ) , âNHCH , âCHO, âCOCH and âCHOHCH ; R is a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; R is a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; R is a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of âO and âNâOR , wherein R is a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of formula (I), the present invention provides methods wherein the compounds of formula (I) are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

6861415, Mar 1, 2005

Apr 30, 1997

09/180132

Hyun K. Kim - Bethesda MD, US
Richard P. Blye - Highland MD, US
Pemmaraju N. Rao - San Antonio TX, US
James W. Cessac - San Antonio TX, US
Carmie K. Acosta - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K031/56
C07J005/00
C07J009/00

514179, 514182, 514841, 552556, 552595, 552598, 552602, 552608

A compound having the general formula: in which: Ris a member selected from the group consisting of —OCH, —SCH, —N(CH), —NHCH, —CHO, —COCHand —CHOHCH; Ris a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; Ris a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; Ris a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR, wherein Ris a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

6900193, May 31, 2005

Mar 17, 2000

09/526855

Hyun K. Kim - Bethesda MD, US
Richard P. Blye - Highland MD, US
Pemmaraju N. Rao - San Antonio TX, US
James W. Cessac - San Antonio TX, US
Carmie K. Acosta - San Antonio TX, US
Anne Marie Simmons - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K031/56
A61K031/58
C07J005/00
C07J009/00
C07J043/00

514179, 514176, 514177, 514182, 514841, 540107, 552556, 552595, 552598, 552602, 552608

The present invention relates, inter alia, to compounds having the general formula: in which: Ris a member selected from the group consisting of —OCH, —SCH, —N(CH), —NHCH, —NCH, —NCH, —NCHO, —CHO, —CH(OH)CH, —C(O)CH, —O(CH)N(CH), and —O(CH)NCH; Ris a member selected from the group consisting of hydrogen, halogen, alkyl, acyl, hydroxy, alkoxy (e. g. , methoxy, ethoxy, vinyloxy, ethynyloxy, cyclopropyloxy, etc. ), acyloxy (e. g. , acetoxy, glycinate, etc. ), alkylcarbonate, cypionyloxy, S-alkyl, —SCN, S-acyl and —OC(O)R, wherein Ris a functional group including, but not limited to, alkyl (e. g. , methyl, ethyl, etc. ), alkoxy ester (e. g. , —CHOCH) and alkoxy (—OCH); Ris a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; Ris a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR, wherein Ris a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat meningiomas; to treat uterine leiomyomas; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce cervical ripening; to induce labor; and for contraception.

6944991, Sep 20, 2005

Dec 29, 2003

10/745591

Hyun T. Kim - Springfield VA, US

E04D013/04
E04D013/064

52 11, 52 12, 52 14, 52 15, 248 481, 248 482

A rain gutter cover for covering the gutter, includes a large space screen a curved upper leg portion extended from a roof shingle for engaging with an upper end of the large space screen, and a plurality of supports attached to the curved front leg portion and to a lower leg portion whereby the rain gutter can keep out leaves and other debris, and allow water to enter thereinto and fall down into the gutter effectively and accurately.

7073277, Jul 11, 2006

Jun 25, 2004

10/877625

Robert Erb - Plandome NY, US
Hyun Jin Kim - Carlsbad CA, US
Marco Grott - San Marcos CA, US

Taylor Made Golf Company, Inc. - Carlsbad CA

A43B 13/38

36 43, 36154, 5253309, 5253325, 5253288, 524504, 524507, 528 44, 528 52, 528 85

The invention relates to the field of shoes in general, and more specifically to the application of microspheres in shoe material formulations to yield desired shoe properties. Even more specifically, the invention relates to a shoe component prepared from a closed cell foam incorporating microspheres to yield controlled cell size, cell size distribution and expansion characteristics. In another embodiment, the invention also relates to an inner sole for a shoe prepared from the reaction product of a polymer matrix component and a curing agent where the curing agent is incorporated in microspheres to yield a material conformable to the user's foot shape.

7087591, Aug 8, 2006

Feb 23, 2005

11/065632

Hyun K. Kim - Bethesda MD, US
Richard P. Blye - Highland MD, US
Pemmaraju N. Rao - San Antonio TX, US
James W. Cessac - San Antonio TX, US
Carmie K. Acosta - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K 31/56
C07J 5/00

514179, 514182, 552595, 552598

A compound having the general formula:In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

7196074, Mar 27, 2007

Oct 28, 2002

10/281794

Richard P. Blye - Highland MD, US
Hyun K. Kim - Bethesda MD, US
Pemmaraju Narasimha Rao - San Antonio TX, US
Carmie Kirk Acosta - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K 31/56
C07J 41/00

514178, 514179, 514182, 514169, 514170, 552525, 552539, 552575, 552632, 552639, 552641, 552515

Methods of using 7α,11β-dimethyl-17β-hydroxyestra-4,14-dien-3-one (III).

7233706, Jun 19, 2007

Jan 4, 2007

11/619926

Hyun Mun Kim - Rockville MD, US
Jong Beom Ra - Taejeon-si, KR
Sung Deuk Kim - Taejeon-si, KR
Young Su Lee - Seoul, KR

LG Electronics Inc. - Seoul

G06T 5/10

382268, 37524027

A method of coding a moving picture is provided that reduces blocking artifacts. The method can include defining a plurality of defining pixels S, S, and S, which are centered around a block boundary. If a default mode is selected then frequency information of the surroundings of the block boundary is obtained. A magnitude of a discontinuous component in a frequency domain belonging to the block boundary is adjusted based on a magnitude of a corresponding discontinuous component selected from a pixel contained entirely within a block adjacent the block boundary. The frequency domain adjustment is then applied to a spatial domain. Or, a DC offset mode can be selected to reduce blocking artifacts in smooth regions where there is little motion.